Matches in Nanopublications for { ?s ?p "[MEF2A was excluded as a candidate for dilated cardiomyopathy (DCM)(LOD of -9.03) and hypertrophic cardiomyopathy (HCM)(LODs of -5.43 and -2.44) in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_assertion description "[MEF2A was excluded as a candidate for dilated cardiomyopathy (DCM)(LOD of -9.03) and hypertrophic cardiomyopathy (HCM)(LODs of -5.43 and -2.44) in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_provenance.
- NP552247.RAY2xHqvtmV6foj_A_8U_Sy6Ree4oCkAIhK_nGNPvbh_w130_assertion description "[MEF2A was excluded as a candidate for dilated cardiomyopathy (DCM)(LOD of -9.03) and hypertrophic cardiomyopathy (HCM)(LODs of -5.43 and -2.44) in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552247.RAY2xHqvtmV6foj_A_8U_Sy6Ree4oCkAIhK_nGNPvbh_w130_provenance.
- NP1369655.RAU5dXjDr6EKdp9qYnDsEIE8iUPi1M4uTB59sjQ_c7Fd8130_assertion description "[MEF2A was excluded as a candidate for dilated cardiomyopathy (DCM)(LOD of -9.03) and hypertrophic cardiomyopathy (HCM)(LODs of -5.43 and -2.44) in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1369655.RAU5dXjDr6EKdp9qYnDsEIE8iUPi1M4uTB59sjQ_c7Fd8130_provenance.
- NP552249.RAjIAg3A4Iv1KLwkT6MA9QMf-PVMJm0gVgHUgjSidGSBM130_assertion description "[MEF2A was excluded as a candidate for dilated cardiomyopathy (DCM)(LOD of -9.03) and hypertrophic cardiomyopathy (HCM)(LODs of -5.43 and -2.44) in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552249.RAjIAg3A4Iv1KLwkT6MA9QMf-PVMJm0gVgHUgjSidGSBM130_provenance.
- NP1369657.RAxkTaYY04to4zZIVjFFKkFn6-sP47ISrq73MDn5YWSXE130_assertion description "[MEF2A was excluded as a candidate for dilated cardiomyopathy (DCM)(LOD of -9.03) and hypertrophic cardiomyopathy (HCM)(LODs of -5.43 and -2.44) in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1369657.RAxkTaYY04to4zZIVjFFKkFn6-sP47ISrq73MDn5YWSXE130_provenance.